NEO
NeoGenomics, Inc.
NEO offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over NEO overall, supported by lower modeled downside and stronger modeled upside.
NEO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Weak |
NEO's revenue is currently healthy, and its profitability is stable, but its cash flow and balance sheet are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
NEO PE Valuation
NEO has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
NEO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
NEO has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
NEO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.29 | — |
| Q3 2026 | -$0.25 | +$0.63 |
| Q2 2026 | -$0.40 | +$0.41 |
| Q1 2026 | -$0.77 | -$0.16 |
| Q4 2025 | -$0.84 | -$0.22 |
| Q3 2025 | -$0.88 | -$0.27 |
| Q2 2025 | -$0.81 | -$0.19 |
| Q1 2025 | -$0.61 | +$0.05 |
| Q4 2024 | -$0.62 | +$0.08 |
NEO is still losing money, but far less than before: $0.25 per share over the past year, against $1.28 at its worst in late 2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over NEO on earnings quality, reporting a profit while its opponent remains loss making.
NEO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $209.3M | +11% |
| Q2 2026 | $201.7M | +11% |
| Q1 2026 | $186.7M | +11% |
| Q4 2025 | $190.2M | +11% |
| Q3 2025 | $187.8M | +12% |
| Q2 2025 | $181.3M | +10% |
| Q1 2025 | $168M | +7.5% |
| Q4 2024 | $172M | +11% |
NEO has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.8% | +11 points |
| Q2 2026 | -4.8% | +21 points |
| Q1 2026 | -9.8% | +6.8 points |
| Q4 2025 | -7% | +3.6 points |
| Q3 2025 | -14% | -1.8 points |
| Q2 2025 | -26% | -13 points |
| Q1 2025 | -17% | +3 points |
| Q4 2024 | -11% | +1.2 points |
NEO's operating margin was −3.8% last quarter, up 11 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over NEO on profitability, with a higher operating margin.
NEO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$20.7M | -3724% |
| Q2 2026 | $11.7M | -16% |
| Q1 2026 | -$13.1M | +$16.7M |
| Q4 2025 | -$6.5M | -$4.7M |
| Q3 2025 | $570K | +$2.1M |
| Q2 2025 | $14M | +1621% |
| Q1 2025 | -$29.8M | +$1.7M |
| Q4 2024 | -$1.8M | -117% |
NEO has burned cash in most quarters: −$29M over the past year, against −$17M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over NEO on cash generation, producing positive trailing cash flow while its opponent burns cash.
NEO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -2.2M shares |
| 1 year | +0.1% | +172K shares |
| 3 years | +2.3% | +2.9M shares |
| 5 years | +4.9% | +6M shares |
| Available history | +19% | +20.8M shares |
NEO has 129M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over NEO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
NEO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 14.9x | High |
| Q2 2021 | 14.7x | High |
| Q1 2021 | -6.3x | Net Cash |
| Q4 2020 | -2.7x | Net Cash |
| Q3 2020 | -4.0x | Net Cash |
| Q2 2020 | -9.4x | Net Cash |
| Q1 2020 | 0.5x | Very low |
| Q4 2019 | -1.6x | Net Cash |
NEO's net debt is about 15 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over NEO on leverage, with a lower net debt burden relative to earnings.
NEO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.5 | Neutral |
| Stochastic | 38.7 | Neutral |
NEO's weekly RSI is 56 (neutral) and its Stochastic is 39 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
NEO PE vs Healthcare Sector
| Metric | NEO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
NEO has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
NEO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.3 | 4.2% below |
| 20 week MA | $16.7 | 0.8% below |
| 50 week MA | $12.9 | 28% above |
| 100 week MA | $11.3 | 46% above |
| 200 week MA | $13.4 | 24% above |
NEO has slipped below its 8- and 20-week averages, though it's still 24% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over NEO on trend strength, trading above more of its moving averages.
NEO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.8 | $55.4 | +86% |
| 2021 | $55.4 | $34.3 | -38% |
| 2022 | $34.3 | $9.17 | -73% |
| 2023 | $9.17 | $16.2 | +76% |
| 2024 | $16.2 | $16.8 | +4% |
| 2025 | $16.8 | $12.3 | -27% |
| 2026 YTD | $12.3 | $16.5 | +35% |
NEO has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.